CHASE is delighted to announce the acquisition of Medacy, a highly reputable provider of pharmacist-led clinical services to the NHS.
Why clinical pharmacists?
Clinical pharmacists are growing in number, responsibility and strategic importance across the UK, with each of England’s 1250 primary care networks (PCNs) likely to employ up to five clinical pharmacists by 2024. The NHS Long Term Plan and the NHS People Plan have committed to investing in this “essential role”, which is becoming the new front line within the NHS.
What does this mean for clients?
CHASE clients will now be able to benefit from deep expertise and practical insights from across 100 NHS GP practices, primary care networks and hospital trusts.
Medacy’s NHS network and expertise also strengthens CHASE’s collaborative working solutions, which will now include the ability to deliver projects remotely. This means remote patient audits and reviews, among other capabilities, will be added to its current expert-led in-clinic services.
Medacy, powered by CHASE’s support and recruitment engines, will now be able to offer its high-quality pharmacist-led clinical services to more GP practices and federations, PCNs and hospital trusts in response to growing demand.
An exciting milestone
The leadership, brands and teams of both companies will remain in position. All clients will see business as usual, with no changes to their existing delivery teams.
Graham Hawthorn, Managing Director of CHASE, said:
“This is an exciting moment which will fuel growth for both companies. Our clients are seeking first-hand insights into how the NHS is changing and wants to engage with industry; this acquisition really enables us to deliver that. We’re also seeing increasing demand for our collaborative working solutions, and they will go from strength to strength with the added expertise of Shaun and his fantastic team.”
Shaun Hockey, Managing Director of Medacy, commented:
“I’m delighted that Medacy is joining forces with CHASE. Medacy has expanded its pharmacist-led clinical services significantly over the last three years and we are still just scratching the surface of clinical pharmacists' potential to transform health services. The experience and expertise of CHASE will support Medacy to realise its full potential, with our businesses sharing the same culture and values that put people first. Though we focus on different elements of healthcare delivery, I’m excited by how our complementary expertise will benefit our NHS and life science partners.”
Want to know more about Medacy?
To find out more, visit www.medacy.co.uk.
Explore our latest thinking, event updates and industry insights to stay informed.
After the breakdown of VPAG negotiations, ABPI & the government agree an extension for VPAG 2026 deadline and an overhaul of NICE’s medicine valuation formula.
%20(1).jpg)
Wes Streeting announces £10 million rollout of 43 neighbourhood health services across England. Find out what it means for pharma, medtech and the NHS.
.png)
Analysing the Life Sciences Sector Plan’s core pillars and the practical implications for organisations in pharmaceuticals, medtech, and NHS & their workforce.
.svg)
